Skip to Content

Menactra Dosage

Generic name: NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN 4ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN 4ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN 4ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN 4ug in 0.5mL
Dosage form: solution for intramuscular injection

Medically reviewed by Drugs.com. Last updated on Jul 23, 2019.

Preparation for Administration

Menactra is a clear to slightly turbid solution. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If any of these conditions exist, the vaccine should not be administered.

Withdraw the 0.5 mL dose of vaccine from the single-dose vial using a sterile needle and syringe.

Dose and Schedule

Menactra is administered as a 0.5 mL dose by intramuscular injection. Do not administer this product intravenously or subcutaneously.

Primary Vaccination:

  • In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart.
  • Individuals 2 through 55 years of age, Menactra is given as a single dose.

Booster Vaccination:

  • A single booster dose may be given to individuals 15 through 55 years of age at continued risk for meningococcal disease, if at least 4 years have elapsed since the prior dose.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.